SonarMD is a leading company in the value-based care coordination program for digestive health, with a focus on proactive, cost-effective care for patients with chronic gut health conditions. The company's approach involves partnering with health plans and providers to align incentives, ensuring timely access to expert support, personalized care pathways, and the best innovations in GI care.
The company's proactive strategy is designed to identify deteriorating symptoms before patients are aware of a problem, enabling care teams to intervene faster and prevent complications, ultimately leading to healthier patients and lower overall care costs. SonarMD has demonstrated the ability to engage 85% of patients, reduce ER visits and hospitalizations by 50%, and drive 15% cost savings per member per year.
Founded in 2015, SonarMD operates in the health care and pharmaceutical industries, with its headquarters in the United States. The company has not disclosed its last investment details or investors.
Key hashtags associated with SonarMD's focus include #guthealth, #digestivehealth, #crohns, #ulcerativecolitis, #IBD, #gastroenterology, and #healthplan.
There is no investment information
No recent news or press coverage available for SonarMD.